Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Asset disposition
Appointed director
CORCEPT THERAPEUTICS INC (CORT) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 144 Form 144 - Report of proposed sale of securities:
10/02/2023 144 Form 144 - Report of proposed sale of securities:
10/02/2023 144 Form 144 - Report of proposed sale of securities:
08/15/2023 144/A Form 144/A - Report of proposed sale of securities: [Amend]
08/14/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 144 Form 144 - Report of proposed sale of securities:
08/07/2023 144 Form 144 - Report of proposed sale of securities:
08/07/2023 144 Form 144 - Report of proposed sale of securities:
08/02/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/02/2023 8-K Quarterly results
Docs: "CORCEPT THERAPEUTICS ANNOUNCES SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE"
06/06/2023 144 Form 144 - Report of proposed sale of securities:
05/24/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: "AMENDED AND RESTATED CERTIFICATE OF INCORPORATION"
05/09/2023 144 Form 144 - Report of proposed sale of securities:
05/08/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/03/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/14/2023 ARS Form ARS - Annual Report to Security Holders:
04/14/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/05/2023 SC TO-I/A Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
04/04/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
04/03/2023 SC TO-I/A Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
03/07/2023 SC TO-I/A Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
03/06/2023 SC TO-I Form SC TO-I - Tender offer statement by Issuer:
02/28/2023 8-K Quarterly results
Docs: "CORCEPT THERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2022 AUDITED FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE"
02/14/2023 5 MAHONEY DAVID L (Director) has filed a Form 5 on CORCEPT THERAPEUTICS INC
02/14/2023 5 WILSON JAMES N (Director) has filed a Form 5 on CORCEPT THERAPEUTICS INC
02/14/2023 5 Robb Gary Charles (Chief Business Officer) has filed a Form 5 on CORCEPT THERAPEUTICS INC
02/14/2023 5 BAKER G LEONARD JR (Director) has filed a Form 5 on CORCEPT THERAPEUTICS INC
02/14/2023 SC 13G/A BAKER G LEONARD JR reports a 5.1% stake in Corcept Therapeutics Incorporated
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2023 8-K Quarterly results
01/20/2023 SC 13G BlackRock Inc. reports a 15.2% stake in CORCEPT THERAPEUTICS INCORPORATED
12/08/2022 8-K Quarterly results
11/03/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/03/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy